Sabra Health Care REIT, Inc. — Form 10-Q
Filed November 2, 2026 · analyzed by the Periodic Agent
10-Q
— Neutral
significance 5/100
What the filing says
CEO Richard K. Matros and CFO Michael Costa certified on November 2, 2026, that the Q3 2026 10-Q filing contains no untrue material statements, that financial statements fairly present the company's condition, and that disclosure controls and internal controls over financial reporting are effective. No changes to internal controls or material weaknesses were disclosed.
Why this rating
Routine SOX compliance certification with no disclosed control deficiencies, material changes, or operational substance.
See more from November 2, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.